Diamyd Medical AB (publ) (DMYD-B) — Capital Reinvestment Ratio
Diamyd Medical AB (publ) (DMYD-B) has a Capital Reinvestment Ratio of 2026.00x as of November 2021, meaning it reinvests 2026% of its operating cash flow (Skr21.00K) in capital expenditures (Skr42.55 Million). See Diamyd Medical AB (publ) (DMYD-B) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Diamyd Medical AB (publ) Capital Reinvestment Ratio (2010–2020)
This chart tracks Diamyd Medical AB (publ)'s Capital Reinvestment Ratio across 2 annual periods. Check Diamyd Medical AB (publ) (DMYD-B) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Diamyd Medical AB (publ) (2010–2020)
Year-by-year Capital Reinvestment Ratio for Diamyd Medical AB (publ) from 2010 to 2020. For live market cap and broader valuation context, see market cap of Diamyd Medical AB (publ).
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.12x | Skr16.88 Million | Skr1.98 Million | ▲ +3681.4% |
| 2010 | 0.00x | Skr225.77 Million | Skr700.00K | — |